Completed PHASE2 INTERVENTIONAL 3-arm NCT00745199

Evaluating the Effect of Cromolyn Sodium in Uremic Pruritus

Phase II Study of the Effect of Oral Cromolyn Sodium on Uremic Pruritus and Serum Tryptase Levels of Hemodialysed Patients

Sponsor: Shiraz University of Medical Sciences

Conditions End Stage Renal Disease Pruritus

Interventions cromolyn sodium placebo

Updated 6 times since 2017 Last updated: Aug 17, 2009 Started: May 31, 2008 Primary completion: Nov 30, 2008 Completion: Jun 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00745199, this PHASE2 trial focuses on End Stage Renal Disease and Pruritus and remains completed. Sponsored by Shiraz University of Medical Sciences, it has been updated 6 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

May 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shiraz University of Medical Sciences

Data source: Shiraz University of Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shiraz, Iran